Published in Adv Exp Med Biol on January 01, 1984
Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis. Science (1967) 7.75
Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorder. Teratology (1997) 4.86
A specific enzyme defect in gout associated with overproduction of uric acid. Proc Natl Acad Sci U S A (1967) 3.29
Newborn screening for Duchenne muscular dystrophy. Pediatrics (1975) 3.09
A robust and cost-effective method for the production of Val, Leu, Ile (delta 1) methyl-protonated 15N-, 13C-, 2H-labeled proteins. J Biomol NMR (1999) 3.02
Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s). Proc Natl Acad Sci U S A (1977) 2.90
Hypoxanthine-guanine phosphoribosyltransferase deficiency in gout. Ann Intern Med (1969) 2.84
The effects of moderate alcohol consumption during pregnancy on fetal growth and morphogenesis. J Pediatr (1978) 2.72
The occurrence of new mutants in the X-linked recessive Lesch-Nyhan disease. Am J Hum Genet (1976) 2.51
Selective methyl group protonation of perdeuterated proteins. J Mol Biol (1996) 2.15
Increased cystine in leukocytes from individuals homozygous and heterozygous for cystinosis. Science (1967) 2.12
The association of waterborne chloroform with intrauterine growth retardation. Epidemiology (1992) 2.10
Biochemical bases of accelerated purine biosynthesis de novo in human fibroblasts lacking hypoxanthine-guanine phosphoribosyltransferase. J Biol Chem (1968) 2.08
Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Pediatr (1976) 2.00
Prenatal cocaine exposure and fetal vascular disruption. Pediatrics (1990) 1.97
Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase. FASEB J (1995) 1.94
Long-range genomic map of the Duchenne muscular dystrophy (DMD) gene: isolation and use of J66 (DXS268), a distal intragenic marker. Genomics (1987) 1.89
Autosomal XX sex reversal caused by duplication of SOX9. Am J Med Genet (1999) 1.87
The fetal hydantoin syndrome. J Pediatr (1975) 1.80
Adenosine kinase initiates the major route of ribavirin activation in a cultured human cell line. Proc Natl Acad Sci U S A (1978) 1.79
Urine uric acid to creatinine rtio--a screening test for inherited disorders of purine metabolism. Phosphoribosyltransferase (PRT) deficiency in X-linked cerebral palsy and in a variant of gout. J Pediatr (1968) 1.76
Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes. Diabetes (1991) 1.75
Binding assays for amino acids. The utilization of a cystine binding protein from Escherichia coli for the determination of acid-soluble cystine in small physiological samples. J Biol Chem (1974) 1.74
Biochemical basis for the enhanced toxicity of deoxyribonucleosides toward malignant human T cell lines. Proc Natl Acad Sci U S A (1979) 1.72
Deletions of different segments of the long arm of chromosome 4. Am J Med Genet (1981) 1.72
Hyperuricemia and gout. Classification, complications and management. N Engl J Med (1979) 1.71
Suppression of metabolic accompaniments of phagocytosis by colchicine. Arthritis Rheum (1965) 1.70
Syndrome of hypotonia-hypomentia-hypogonadism-obesity (HHHO) or Prader-Willi syndrome. Am J Dis Child (1968) 1.69
Abnormality of chromosome 11 in patients with features of Beckwith-Wiedemann syndrome. J Pediatr (1983) 1.68
Purification and properties of a ribose-binding protein from Escherichia coli. J Biol Chem (1974) 1.62
Variable stability of a selectable provirus after retroviral vector gene transfer into human cells. Mol Cell Biol (1986) 1.62
Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci U S A (1991) 1.61
Spondylo-meta-epiphyseal dysplasia (SMED), short limb-hand type: a congenital familial skeletal dysplasia with distinctive features and histopathology. Am J Med Genet (1993) 1.60
Magnetic resonance imaging of brain anomalies in fetal alcohol syndrome. Pediatrics (1997) 1.59
Geleophysic dysplasia: a storage disorder affecting the skin, bone, liver, heart, and trachea. J Pediatr (1990) 1.58
Increased free-cystine content of fibroblasts cultured from patients with cystinosis. Biochem Biophys Res Commun (1967) 1.58
An enzymatic spectrophotometric method for the determination of xanthine and hypoxanthine. Clin Chem (1967) 1.57
Holoprosencephaly in infants of diabetic mothers. J Pediatr (1983) 1.51
Regulation of Glutamine Transport in Escherichia coli. J Bacteriol (1975) 1.51
Phylogenies inferred from mitochondrial gene orders-a cautionary tale from the parasitic flatworms. Mol Biol Evol (2000) 1.50
Oculodentodigital dysplasia. Four new reports and a literature review. Arch Ophthalmol (1979) 1.50
Assessment of reproductive disorders and birth defects in communities near hazardous chemical sites. I. Birth defects and developmental disorders. Reprod Toxicol (1997) 1.50
Autosomal recessive cerebellar hypoplasia. J Child Neurol (1989) 1.49
Evidence for intergenic complementation in hybrid cells derived from two human diploid strains each carrying an X-linked mutation. Proc Natl Acad Sci U S A (1969) 1.48
Urinary xanthine stones--a rare complications of allopurinol therapy. N Engl J Med (1969) 1.45
An enzymatic basis for variation in response to allopurinol. Hypoxanthine-guanine phosphoribosyltransferase deficiency. N Engl J Med (1968) 1.45
Hypoxanthine-guanine phosphoribosyltransferase deficiency: activity in normal, mutant, and heterozygote-cultured human skin fibroblasts. Proc Natl Acad Sci U S A (1970) 1.42
Cardiac manifestations of the mucopolysaccharidoses. Circulation (1975) 1.41
Long-term calcitonin therapy in postmenopausal osteoporosis. Metabolism (1984) 1.41
Is lysergic-acid diethylamide a teratogen? Lancet (1967) 1.41
Adenine and adenosine are toxic to human lymphoblast mutants defective in purine salvage enzymes. Science (1977) 1.40
Differential sensitivity of human leukemic T cell lines and B cell lines to growth inhibition by deoxyadenosine. J Immunol (1978) 1.40
Adenosine deaminase deficiency and severe combined immunodeficiency disease. Adv Enzymol Relat Areas Mol Biol (1980) 1.39
Web neck anomaly and its association with congenital heart disease. Am J Med Genet (1995) 1.39
Retroviral vector-mediated gene transfer into human hematopoietic progenitor cells. Science (1985) 1.39
Fetal alcohol syndrome. Experience with 41 patients. JAMA (1976) 1.39
Further studies of a thymus nucleohistone-associated protease. J Biol Chem (1970) 1.39
Adenine phosphoribosyltransferase deficiency: a previously undescribed genetic defect in man. J Clin Invest (1968) 1.38
New prospects for understanding and control of genetic diseases. Arch Intern Med (1972) 1.38
Medical Communication Behavior System. An interactional analysis system for medical interactions. Med Care (1986) 1.38
Xanthine oxidase activity in human tissues and its inhibition by allopurinol (4-hydroxypyrazolo[3,4-d] pyrimidine). J Lab Clin Med (1965) 1.37
The acute attack of gouty arthritis. Arthritis Rheum (1965) 1.37
The presence of a kinin in inflammatory synovial effusion from arthritides of varying etiologies. Arthritis Rheum (1967) 1.36
Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis. J Clin Invest (1976) 1.36
Saethre-Chotzen syndrome: a broad and variable pattern of skeletal malformations. J Pediatr (1977) 1.35
Inherited disorder of purine metabolism. Correlation between central nervous system dysfunction and biochemical defects. JAMA (1967) 1.34
An enzymatic determination of ammonia in biological fluids. J Lab Clin Med (1965) 1.34
Biochemical diagnosis of an X-linked disease in utero. Lancet (1968) 1.34
Regulation of de novo purine biosynthesis in human lymphoblasts. Coordinate control of proximal (rate-determining) steps and the inosinic acid branch point. J Biol Chem (1976) 1.34
Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc Natl Acad Sci U S A (1998) 1.33
Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action. Metabolism (1983) 1.32
Lesch-Nyhan syndrome: preventive control by prenatal diagnosis. Science (1970) 1.31
Altered regulation of Epstein-Barr virus induced lymphoblast proliferation in rheumatoid arthritis lymphoid cells. Arthritis Rheum (1980) 1.31
Adenosine metabolism in phytohemagglutinin-stimulated human lymphocytes. J Clin Invest (1976) 1.29
Small structural changes of chromosome 8. Two cases with evidence for deletion. Hum Genet (1977) 1.28
Kinetic studies of hypoxanthine-guanine phosphoribosyltransferase. J Biol Chem (1968) 1.28
Superoxide dismutase activity of normal murine liver, regenerating liver, and H6 hepatoma. J Natl Cancer Inst (1978) 1.27
Double trisomy and double trisomic mosaicism. Am J Dis Child (1967) 1.27
Cystine: compartmentalization within lysosomes in cystinotic leukocytes. Science (1969) 1.27
Experimental myopathy after microarterial embolization; comparison with childhood x-linked pseudohypertrophic muscular dystrophy. Arch Neurol (1970) 1.26
Expression of purine overproduction in a series of 8-azaguanine-resistant diploid human lymphoblast lines. Proc Natl Acad Sci U S A (1974) 1.25
Effects of ascorbic acid in alkaptonuria: alterations in benzoquinone acetic acid and an ontogenic effect in infancy. Pediatr Res (1989) 1.25
Stimulation of human purine synthesis de novo by fructose infusion. Metabolism (1975) 1.25
Answer to criticism of Morton and Lalouel. Am J Hum Genet (1977) 1.24
A new approach for carrier detection in Duchenne muscular dystrophy. Protein synthesis of muscle polyribosomes in vitro. Neurology (1971) 1.23
Purine overproduction in man associated with increased phosphoribosylpyrophosphate synthetase activity. Science (1973) 1.23
Mouth and genital ulcers with inflamed cartilage: MAGIC syndrome. Five patients with features of relapsing polychondritis and Behçet's disease. Am J Med (1985) 1.22
Prevention of pulmonary vascular changes of chronic alveolar hypoxia by inhibition of angiotensin I-converting enzyme in the rat. Lab Invest (1975) 1.22
Age-related physiological changes and their clinical significance. West J Med (1981) 1.21
Criteria for identifying and listing substances known to cause developmental toxicity under California's Proposition 65. Reprod Toxicol (1989) 1.20
Cystinosis. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med (1968) 1.20
Brachyolmia: radiographic and genetic evidence of heterogeneity. Am J Med Genet (1989) 1.20
Differential effects of aging on human chondrocyte responses to transforming growth factor beta: increased pyrophosphate production and decreased cell proliferation. Arthritis Rheum (1997) 1.19
Familial occurrence of Ivemark syndrome with splenic hypoplasia and asplenia in sibs. J Med Genet (1973) 1.19
Heritable spinal muscular atrophies. Helv Paediatr Acta (1969) 1.19
Synthesis of phosphoribosylpyrophosphate in mammalian cells. Adv Enzymol Relat Areas Mol Biol (1979) 1.18
Letter: Incidence of conjoined twinning. Lancet (1975) 1.16
A large family with features of pseudoachondroplasia and multiple epiphyseal dysplasia: exclusion of seven candidate gene loci that encode proteins of the cartilage extracellular matrix. Hum Genet (1994) 1.16